Mirdametinib

Cat. No.: IBDI-435341

Mirdametinib (PD0325901) (GMP) is Mirdametinib (HY-10254) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Mirdametinib is an orally active, selective and non-ATP-competitive MEK inhibitor.

Product Details

Target	MEK
Molecular Weight	482.19
Synonyms	PD0325901, PD325901
SMILES	O=C(C1=CC=C(C(F)=C1NC2=CC=C(I)C=C2F)F)NOC[[email protected]](O)CO

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.